147 related articles for article (PubMed ID: 38178729)
1. Different effects of CO
Qi Y; Mo K; Wang A; He Y
J Obstet Gynaecol Res; 2024 Apr; 50(4):671-681. PubMed ID: 38178729
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
Wallace SL; St Martin B; Lee K; Sokol ER
Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
[TBL] [Abstract][Full Text] [Related]
3. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
Cruff J; Khandwala S
J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
[TBL] [Abstract][Full Text] [Related]
4. The Fractional CO
Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
[TBL] [Abstract][Full Text] [Related]
5. [Short-term efficacy of vaginal CO
Kozma B; Póka R; Sipos A; Ács N; Takács P
Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
7. Use of a vaginal CO
Mejia-Gomez J; Bouteaud J; Philippopoulos E; Wolfman W; Brezden-Masley C
Climacteric; 2022 Jun; 25(3):228-234. PubMed ID: 34694948
[TBL] [Abstract][Full Text] [Related]
8. Fractional and Microablative CO
Caceres Nogueira MC; Homem de Mello Bianchi-Ferraro AM; Leonor Pereira Campos M; Dias Oliveira C; Gracio Ferreira Sartori M; Di Bella ZIKJ; Logullo AF; ; Speck NMG
Photobiomodul Photomed Laser Surg; 2024 Jun; 42(6):414-421. PubMed ID: 38888192
[No Abstract] [Full Text] [Related]
9. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
[TBL] [Abstract][Full Text] [Related]
10. The effect of CO
Latul YP; Vodegel EV; Kastelein AW; Alkemade L; Ras L; Hilty MP; Favaron E; Ince Y; Ince C; Jeffery S; Guler Z; Roovers JWR
Neurourol Urodyn; 2023 Aug; 42(6):1381-1389. PubMed ID: 37334848
[TBL] [Abstract][Full Text] [Related]
11. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fractional CO
Tovar-Huamani J; Mercado-Olivares F; Grandez-Urbina JA; Pichardo-Rodriguez R; Tovar-Huamani M; García-Perdomo H
Lasers Surg Med; 2019 Aug; 51(6):509-515. PubMed ID: 30779363
[TBL] [Abstract][Full Text] [Related]
13. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
14. CO
Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
[TBL] [Abstract][Full Text] [Related]
15. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause.
Seganfredo IB; Bianchi C; Tacla M; Chedraui P; Haddad JM; Simoes R; Baracat EC; Soares JM
Maturitas; 2024 Aug; 186():108008. PubMed ID: 38714422
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis.
Jang YC; Leung CY; Huang HL
JAMA Netw Open; 2022 Sep; 5(9):e2232563. PubMed ID: 36129710
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
18. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
Sokol ER; Karram MM
Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
[TBL] [Abstract][Full Text] [Related]
19. Safety and long-term efficacy of fractional CO
Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
[TBL] [Abstract][Full Text] [Related]
20. Microablative fractional CO
Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
